Manifest Investing

Company	Ticker	Sector \| Industry	Quality	PAR
Gilead Sciences	GILD	Healthcare \| Drug Manufacturers - General	44	6.5%

Current Price ( 5/26 4:00PM EDT)			$77.09
CAPS Rating (Rate this stock on CAPS)

Expected Income Statement
Current Sales			27,043.0
Sales Growth Forecast			0.5%
Net Profit Margin			27.6%

Projected Shares Outstanding			1,234.96
EPS - Five year Forecast			$6.20
Average P/E Ratio			14.0
Projected Average Price			$86.81

Price Appreciation (Annualized)			2.4%
Annual Dividend Yield			4.1%
Projected Annual Return			6.5%

Quality
Financial Strength			46	11.5
EPS Stability			46	11.6
Industry Sales Growth Rate			4.0%	1.6
Industry Net Profit Margin			19.3%	17.9
Calculated Quality Rating			42.6

Fool CAPS
Total Players 3341 Outperforms 90 Underperforms All-Stars (624) 613 Outperforms (98%) 11 Underperforms

Fundamental Data Updated: 04/28/2023

MIPAR	11.7%
Sweet Spot	16.7% - 21.7%

Quality Legend:
Blue	Excellent with quality greater than 80.
Green	Good with quality between 60 and 80.
Neutral	Average or below average with quality between 20 and 60.
Red	Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green	PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow	PAR is above the target range of MIPAR +10%, currently 10.1%
PAR	Projected Annual Return
MIPAR	The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
*	Not covered by Value Line Standard Edition.
b	Uses price-to-book value for valuation purposes.
P/CF	Uses price-to-cash flow for valuation.